Charles River Laboratories International (CRL) Capital Expenditures Growth (3y) (2012 - 2025)
Charles River Laboratories International (CRL) Capital Expenditures Growth (3y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 16.58% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -6.49% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -3.55% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 10.06% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 7.36% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 139.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -5.23% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -1.12% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 9.89% |
| 10 | Charles River Laboratories International | 12.89 Bn | 12.68 Bn | 1.81 Bn | -0.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | -0.03% |
| Sep 27, 2025 | -21.08% |
| Jun 28, 2025 | -24.75% |
| Mar 29, 2025 | -9.66% |
| Dec 28, 2024 | -8.52% |
| Sep 28, 2024 | -11.33% |
| Jun 29, 2024 | -5.26% |
| Mar 30, 2024 | 41.34% |
| Dec 30, 2023 | 51.47% |
| Sep 30, 2023 | 36.05% |
| Jul 1, 2023 | 35.98% |
| Apr 1, 2023 | 60.77% |
| Dec 31, 2022 | 11.72% |
| Sep 24, 2022 | 27.21% |
| Jun 25, 2022 | 49.53% |
| Mar 26, 2022 | 68.80% |
| Dec 25, 2021 | 12.88% |
| Sep 25, 2021 | 35.27% |
| Jun 26, 2021 | 29.84% |
| Mar 27, 2021 | 0.36% |